leisure time -WSS

leisure time

author：entertainment 2025-10-02 13:01:39 - browse：69

Vertex Pharmaceuticals Inc. building — Craig F. Walker/The Boston Globe

Vertex Pharmaceuticals said Friday that, over a year after receiving the company’s stem-cell therapy, two type 1 diabetes patients no longer need to take insulin injections and saw stark reductions in a biological marker of disease.

The results, presented at the American Diabetes Association conference in San Diego, bolstered experts’ hopes that the treatment could provide a functional cure for some patients. In 2021, Vertex announced dramatic results from the first man to receive the treatment, but researchers cautioned it was just one person, who had only been followed for 90 days.

“The data look as good as they could be,” said Jeanne Loring, a stem cell expert and professor emeritus at Scripps Research not involved in the work, in an email.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Free medical tuition alone isn't enough to close gaps in primary care

knowledge

hotspot

WSS

As H5N1 spreads in cows, experts warn against drinking raw milk

Drug cartel violence flares in western Mexico after vigilante leader's killing

What a koala virus tells us about the human genome

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Oak Street deal isn't the answer to health care's woes

Vertex cell therapy lets patients with type 1 diabetes stop insulin

entertainment

leisure time

hotspot

The high cost of giving birth even with insurance

STAT reporters are Pulitzer Prize finalists for investigative reporting

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT reporters are Pulitzer Prize finalists for investigative reporting

Tori Bowie and the unacceptable rates of Black maternal death

As H5N1 spreads in cows, experts warn against drinking raw milk

Medical records are filled with copy

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Apple is now the first public company to be valued at $3 trillion

CVS is willing to dump 10% of its Medicare Advantage members

hotspot

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

How Robert F. Kennedy Jr. distorted vaccine science

Fertility clinic egg and embryo storage is a disaster

STAT reporters are Pulitzer Prize finalists for investigative reporting

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Abbott's new stent may help patients with peripheral artery disease

leisure time

knowledge

hotspot

focus